Central Pharmaceutical Research Institute (CPRI)
Central Pharmaceutical Research Institute (CPRI) is recorded as a service provider in 1 clinical trial. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 1 of 1 trials · Latest update first
A Phase 2a, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety and Tolerability of JTT-861 Administered for 12 Weeks in Subjects with Heart Failure with Reduced Ejection Fraction (POWER-HF)
Sponsor Akros Pharma Inc.
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Central Pharmaceutical Research Institute (CPRI)?
The 2026-10-09 snapshot links Central Pharmaceutical Research Institute (CPRI) to 1 distinct CTIS trials. Recorded services include Laboratory services. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Central Pharmaceutical Research Institute (CPRI)?
The most frequently recorded therapeutic areas are Cardiology. Recorded phases include Phase 2. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Central Pharmaceutical Research Institute (CPRI) conducted?
The linked trials record locations in 5 countries, including Bulgaria, Czechia, Spain, Poland, Romania. These are trial locations, not confirmed office locations or countries where Central Pharmaceutical Research Institute (CPRI) delivered services.
What can this page tell me about Central Pharmaceutical Research Institute (CPRI)'s trial experience?
Browse 1 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Central Pharmaceutical Research Institute (CPRI). Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Central Pharmaceutical Research Institute (CPRI)